Skip to Content

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Dr. Ana K. Stankovic, MD, PhD, Appointed to Fluidigm Board of Directors
SOUTH SAN FRANCISCO, Calif. , Dec. 15, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K.
View HTML
Toggle Summary Key Regulatory Body in India Grants Commercial License for Fluidigm Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay
Fluidigm Assay is Among First Saliva-Based COVID-19 Tests Licensed for Use by Designated Labs in India SOUTH SAN FRANCISCO, Calif. , Nov. 24, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation  (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive
View HTML
Toggle Summary Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif. , Nov. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company’s management will participate in the Piper Sandler
View HTML
Toggle Summary Study Utilizing Imaging Mass Cytometry Details Changes in Lung Tissue Architecture at the Single-Cell Level in Patients with COVID-19
Weill Cornell Medicine Researchers Utilize Fluidigm Hyperion Imaging System to Identify a Phenotype of Immune Cell Activity Distinct from Other Lung Infections A Framework for Data-Driven Spatial Understanding of Lung Pathology to Inform New Treatment Approaches for COVID-19 SOUTH SAN FRANCISCO,
View HTML
Toggle Summary Fluidigm COVID-19 Community Connect Program Builds a Network of Testing Partners to Increase Access of Saliva-Based SARS-CoV-2 Testing for Communities
SOUTH SAN FRANCISCO, Calif. , Nov. 17, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation  (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced COVID-19 Community Connect, a program to link federal, state and local
View HTML
Toggle Summary Fluidigm to Present at Upcoming Health Care Investor Conference
SOUTH SAN FRANCISCO, Calif. , Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in investor meetings and
View HTML
Toggle Summary Fluidigm Announces Third Quarter 2020 Financial Results
Third   Q uarter T otal R evenue I n creased 50   P ercent to $ 39 .9   M illion Third Q uarter P roduct and Service R evenue I ncreased 34   P ercent to   $35 . 3 M illion   D riven by COVID-19 T esting GAAP N et L oss in the T hird Q uarter Was $6.0   M illion ; Non-GAAP N et I ncome W as $2.5  
View HTML
Toggle Summary Fluidigm and Healthvana Partner to Offer COVID-19 Test Results Delivery through Innovative Digital Platform
Patients Receive Results, Education and Next Steps on Their Mobile Phones to Prevent Further Spread of the Disease SOUTH SAN FRANCISCO, Calif. , Nov. 05, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation  (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through
View HTML
Toggle Summary Fluidigm Mass Cytometry Technologies, Including CyTOF, Imaging Mass Cytometry and Maxpar Direct, Utilized in More than 100 National Clinical Trials
25 Trials Utilizing Mass Cytometry Initiated in 2020 SOUTH SAN FRANCISCO, Calif. , Nov. 03, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that its mass
View HTML
Toggle Summary Dante Labs Launching COVID-19 Testing in Europe Utilizing Fluidigm Pathogen Detection Kit on Biomark HD Platform
Global Pioneer in Direct-to-Consumer Genomic Testing Chooses Fluidigm Saliva-Based Solution Fluidigm   Powered Testing Service to be Rolled Out in Seven European Countries SOUTH SAN FRANCISCO, Calif. , Nov. 02, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation  (Nasdaq:FLDM), an innovative
View HTML